Why the study?
Bleeding and drug resistance are the most common side effects of clinically used antiplatelet drugs, making it important to identify new antiplatelet agents that avoid or reduce these complications.
Does protocatechuic acid inhibit high shear stress-induced platelet aggregation in human blood samples?
Comparison
Protocatechuic acid vs CD42b, aspirin, tirofiban, and other drugs
Design
In vitro microfluidic chip study
Authors
Loading...
Microfluidic model may aid safer antiplatelet screening; leaves open clinical translation and efficacy.
Does protocatechuic acid inhibit high shear stress-induced platelet aggregation in human blood samples?
Protocatechuic acid selectively inhibits high shear stress-induced platelet aggregation via the GP1b-vWF pathway without impairing normal coagulation, suggesting potential as a novel antithrombotic agent.
He et al. (2020) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: